TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for Northern District of California against Amyris, Inc.

Globe Newswire 18-Apr-2019 4:15 PM

NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ:AMRS) in the United States District Court for the Northern District of California on behalf of those who purchased or acquired the securities of Amyris between March 15, 2018 and March 19, 2019, inclusive (the "Class Period").

Investors who purchased shares of Amyris, Inc. are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website www.whafh.com.

If you have incurred losses in the shares of Amyris, Inc., you may, no later than June 3, 2019, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Amyris, Inc.

## Follow the firm and learn about newly filed cases on Twitter and Facebook. ## 

The filed Complaint alleges that Defendants concealed from the investing public:

  • that the Company lacked sufficient resources to accurately account for certain
    transactions;
     
  • that, as a result, there was a material weakness in the Company's internal controls over financial reporting;
     
  • that, as a result, the Company would be unable to timely file its annual report; and
     
  • that,  as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. 

On March 19, 2019, the Company disclosed that it would be unable to timely file its annual report due to "significant time and  resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018." The Company also disclosed that it "is in the process of completing  its evaluation of internal control over financial reporting and may have  further deficiencies to report." 

On this news, shares of Amyris declined over 20%, closing at $3.10 per share on March 20, 2019.

Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com

Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

Image for Press Release 800094

wolf_logo_color_tagline.jpg

Image for Press Release 800094